Class / Patent application number | Description | Number of patent applications / Date published |
424737000 | Containing or obtained from Echinacea (e.g., coneflower, etc.) | 30 |
20090074893 | Antiviral peptides - The invention provides a method for the prevention or treatment of virus infections comprising administering, to a human or animal individual susceptible to or suffering from a virus infection, an effective amount of one or more casein phosphopeptides (CPP). Also provided is a composition containing such casein peptides and further agents such as vitamin C and/or nutritional components for use in treating or preventing virus infections. | 03-19-2009 |
20090191288 | Composition to Treat Herpes, Pseudomonas, Staph, Hepatitis and Other Infectious Diseases - An improved method (process) and medicinal composition is provided to treat herpes, pseudomonas, hepatitis, staph (staphylococci) and other infectious diseases The inexpensive medicinal composition can be self-administered and maintained for a prescribed time. The attractive medicinal composition can comprise a quaternary ammonium salt surfactant, a skin protectant and an alcohol. The quaternary ammonium salt surfactant can comprise benzalkonium halide, preferably benzalkonium chloride. The skin protectant can comprise Allantoin. The alcohol can serve as a pain reliever and can comprise benzyl alcohol. The medicinal composition can also include other compounds, additives, herbal extracts and/or carriers. | 07-30-2009 |
20100112101 | BIO-AVAILABILITY/BIO-EFFICACY ENHANCING ACTIVITY OF STEVIA REBAUDIANA AND EXTRACTS AND FRACTIONS AND COMPOUNDS THEREOF - The present invention discloses bio-efficacy and bio-availability enhancing composition comprising, an effective amount of | 05-06-2010 |
20100151062 | Determining nutrients for animals through gene expression - Genetic information of DNA polymorphism, the functional genomic profile and the different response of an animal to a biologically active nutrient are used to identify the biologically active nutrient composition of the diet for an animal. The response to a nutrient exposure is dynamic since it depends upon the polymorphism of nutritionally inducible genes (as SNPs) that can lead to a different effect of the same nutrient in animals having different genotypes. The assessment of the biologically active nutrient composition of the diet arises from using reference data relating to normal healthy animals with different genotypes, target data relating to unhealthy animals with different genotypes, and nutritional data relating to a different effect of biologically active nutritional compounds in animals with different genotypes. Analysis is affected by relating gene, protein or metabolite expression. | 06-17-2010 |
20100159036 | USE AS A MEANS TO IMPROVE FERTILITY OF A PHYTOTHERAPEUTIC COMPOSITION AND METHOD FOR IMPROVING AND/OR PROMOTING FERTILITY HEALTH - A method of using a phytotherapeutic composition to improve fertility health in mammals, includes the steps of providing the phytotherapeutic composition having extracts of | 06-24-2010 |
20100310684 | METHODS FOR TREATING AND PREVENTING MUCOSITIS - Methods for treating and preventing mucositis, in particular mucositis following the administration of chemotherapy drugs or a combination of said drugs with radiotherapy, are disclosed herein. More specifically, disclosed herein is the administration of a therapeutically effective amount of at least one of an anthocyanoside, a proanthocyanidin, or an extract containing at least one of an anthocyanoside or a proanthocyanidin for the treatment or prevention of mucositis. The therapeutically effective amount of the anthocyanoside, proanthocyanidin or extract can be administered alone or in combination with a therapeutically effective amount of at least one of an anti-inflammatory agent, immunomodulating agent, analgesic, antimicrobial agent or antifungal agent. Also disclosed herein are pharmaceutical compositions for treating and preventing mucositis. | 12-09-2010 |
20110014306 | FORMULATIONS WITH SANGUINARINE, CHELERYTHRINE OR CHELIDONINE FOR THE TREATMENT OF WARTS, VERRUCAS AND PSORIATIC PLAQUES - The invention provides formulations containing sanguinarine, chelerythrine or chelidonine or their salts or extracts containing them, mixed with suitable vehicles and/or excipients, for the treatment of common skin warts and verrucas, anal and vulvar warts and psoriatic plaques. | 01-20-2011 |
20110059194 | ECHINACEA FORMULATION - The present invention relates to an Echinacea formulation which includes an alkylamide fraction comprising a 2-ene alkylamide fraction and a 2,4-diene alkylamide fraction and the weight ratio of the 2-ene alkylamide fraction to the 2,4-diene alkylamide fraction is between about 1:15 to about 2:1. | 03-10-2011 |
20110104313 | COMPOSITIONS FOR THE TREATMENT OF VAGINAL INFECTIONS WITH CHRONIC INFLAMMATION - The present invention relates to compositions comprising benzofuran compounds and benzophenanthridine alkaloids, which possess anti-inflammatory, antibacterial and antifungal activity useful in the treatment of vaginal infections and the resulting inflammatory states. | 05-05-2011 |
20110151032 | TOPICAL ANTI-INFLAMMATORY COMBINATION - Provided, among other things, is a method of treating or ameliorating an indication of non-mucosal topical tissue comprising periodically applying to such disease affected tissue a composition comprising: an effective amount of an appropriate composition of herbal bioactive comprising active(s) of one or more of | 06-23-2011 |
20110311659 | COMPOSITION AND METHOD OF TREATING LIPID ENCAPSULATED VIRUS INFECTIONS - A method of treating a patient infected with a lipid encapsulated virus by administering to the patient about 1000 mg to about 5000 mg per day of a nutritional supplement having from about 40 to about 80 wt. % L-lysine, from about 20 to about 50 wt. % butylated hydroxytoluene and from about 1 to about 10 wt. % | 12-22-2011 |
20120027879 | BUCCAL, POLAR AND NON-POLAR SPRAY OR CAPSULE CONTAINING DRUGS FOR TREATING METABOLIC DISORDERS - Buccal aerosol sprays or capsules using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, active compound, and optional flavoring agent; formulation II: aqueous polar solvent, active compound, optionally flavoring agent, and propellant; formulation III: non-polar solvent, active compound, and optional flavoring agent; and formulation IV: non-polar solvent, active compound, optional flavoring agent, and propellant. | 02-02-2012 |
20120040031 | COMPOSITIONS COMPRISING LIPOPHILIC EXTRACTS OF ZINGIBER OFFICINALE AND ECHINACEA ANGUSTIFOLIA FOR THE PREVENTION AND TREATMENT OF GASTRO-OESOPHAGEAL REFLUX AND CHEMOTHERAPY-INDUCED EMESIS - The present invention relates to compositions consisting of a combination of lipophilic extracts of | 02-16-2012 |
20120082738 | MUCOSAL FORMULATION - Provided, among other things, is a method of treating or ameliorating an indication of mucosal or adjacent tissue comprising periodically applying to mucosa at or adjacent to disease affected tissue a rinse comprising: an effective amount of appropriate composition of herbal bioactive comprising active(s) of one or more of | 04-05-2012 |
20120121737 | COMPOSITIONS COMPRISING TRANS-TERT-BUTYL CYCLOHEXANOL AS SKIN IRRITATION-REDUCING AGENT - The present invention primarily relates to the use of trans-tert-butyl cyclohexanol as skin irritation-reducing agent as well as compositions (formulations) having a skin irritation-reducing action comprising trans-tert-butyl cyclohexanol as skin irritation-reducing agent. | 05-17-2012 |
20120231096 | COMPOSITION AND METHOD OF TREATING LIPID ENCAPSULATED VIRUS INFECTIONS - A method of treating a patient infected with a lipid encapsulated virus by administering to the patient about 1000 mg to about 5000 mg per day of a nutritional supplement having from about 40 to about 80 wt. % L-lysine, from about 20 to about 50 wt. % butylated hydroxytoluene and from about 1 to about 10 wt. % | 09-13-2012 |
20120263810 | FORMULATIONS WITH SANGUINARINE, CHELERYTHRINE OR CHELIDONINE FOR THE TREATMENT OF WARTS, VERRUCAS AND PSORIATIC PLAQUES - The invention provides formulations containing sanguinarine, chelerythrine or chelidonine or their salts or extracts containing them, mixed with suitable vehicles and/or excipients, for the treatment of common skin warts and verrucas, anal and vulvar warts and psoriatic plaques. | 10-18-2012 |
20120321727 | TASTE MASKING COMPOSITIONS AND EDIBLE FORMS THEREOF - Disclosed are edible formulations, for example, edible films and gummi confectioneries, that mask the taste of semen. The films and confectioneries include a composition that upon activation in the oral cavity provides a lasting taste masking effect that endures for up to 20 minutes. The composition includes a film former or gelling agent, an effective amount of a protein masker, and an effective amount of a bitter masker. The composition may also include a flavoring agent, sweetening agents, and sensates. | 12-20-2012 |
20130108720 | COMPOSITIONS COMPRISING LIPOPHILIC EXTRACTS OF ZINGIBER OFFICINALE AND ECHINACEA ANGUSTIFOLIA FOR THE PREVENTION AND TREATMENT OF GASTRO-OESOPHAGEAL REFLUX AND CHEMOTHERAPY-INDUCED EMESIS | 05-02-2013 |
20130122124 | MUCOSAL FORMULATION - Provided, among other things, is a method of treating or ameliorating an indication of mucosal or adjacent tissue comprising periodically applying to mucosa at or adjacent to disease affected tissue a rinse comprising: an effective amount of appropriate composition of herbal bioactive comprising active(s) of one or more of | 05-16-2013 |
20130236575 | COMPOSITIONS FOR THE TREATMENT OF PERIPHERAL ULCERS OF VARIOUS ORIGINS - The present invention relates to compositions containing a combination of a cell proliferation-stimulating agent with vasokinetic properties and an antimicrobial, antifungal and antiviral agent with an anti-inflammatory/analgesic, which is useful in the treatment of peripheral ulcers of various origins, such as diabetic ulcers, ulcers caused by venous stasis of the limbs, bedsores and the associated skin infections. Said combination could be presented as formulations for topical or systemic use. | 09-12-2013 |
20130266672 | FORMULATIONS CONTAINING EXTRACTS OF ECHINACEA ANGUSTIFOLIA AND ZINGIBER OFFICINALE WHICH ARE USEFUL IN REDUCING INFLAMMATION AND PERIPHERAL PAIN - Disclosed is a combination of lipophilic extracts of | 10-10-2013 |
20130316026 | XYLITOL-BASED ANTI-MUCOSAL COMPOSITIONS AND RELATED METHODS AND COMPOSITIONS - Compositions and methods for alleviating an allergy condition while also reducing a drying effect of an allergy medication or another anti-mucosal composition. In some embodiments, a nasal solution for alleviating an allergy condition may comprise an anti-mucosal composition in an amount effective for treating an allergy condition and at least one of xylitol and xylose in an amount effective for reducing nasal dryness caused by the anti-mucosal composition. | 11-28-2013 |
20140099389 | TOPICAL ANTI-INFLAMMATORY COMBINATION - Provided, among other things, is a method of treating or ameliorating an indication of non-mucosal topical tissue comprising periodically applying to such disease affected tissue a composition comprising: an effective amount of an appropriate composition of herbal bioactive comprising active(s) of one or more of | 04-10-2014 |
20140220165 | COMPOSITIONS FOR THE TREATMENT OF PERIPHERAL ULCERS OF VARIOUS ORIGINS - The present invention relates to combinations of an agent that stimulates cell proliferation and an anti-inflammatory/analgesic, which are useful in the treatment of peripheral ulcers of various origins, such as radiation dermatitis, diabetic ulcers, ulcers caused by venous stasis of the limbs, bedsores, and the associated skin infections, proctitis, vulvovaginitis and haemorrhoids with vascular lesions. These combinations can be presented as formulations for topical use. | 08-07-2014 |
20150050366 | Medical Delivery Devices and Methods for Applying a Barrier Composition to a Targeted Skin Surface - Some embodiments of a system or method for applying a barrier composition to a targeted skin surface can be used to as a preventative measure to reduce the likelihood of transmission of microbial entities from an external source (e.g., a floor surface or another surface) to the targeted skin surface. | 02-19-2015 |
20150140137 | COMBINED ALLERGY TREATMENT AND ANTI-DRYING COMPOSITIONS AND RELATED METHODS - Compositions and methods for alleviating an allergy condition while also reducing a drying effect of an allergy treatment composition or another anti-mucosal composition. In some embodiments and implementations, a composition may be provided comprising an allergy treatment composition comprising an antihistamine in a therapeutically effective amount for treating the allergy condition in the human having the allergy condition. The composition may further comprise an anti-drying composition comprising at least one of xylitol, erythiritol, mannitol, maltitol, tibitol, arabitol, ribose, and xylose in one or more therapeutically effective amounts for reducing nasal dryness caused by the allergy treatment composition. The composition may be delivered into at least one of the human's nose, eyes, mouth, and throat. | 05-21-2015 |
20160000731 | SORE-THROAT COMPOSITIONS AND RELATED METHODS - Methods for alleviating sore throat conditions and related compositions. In some such compositions, at least one non-hexose sugar alcohol and/or at least one non-hexose sugar alcohol precursor may be present in a concentration effective for reducing a concentration of sore-throat causing microorganisms in a patient's throat. The composition may further comprise at least one coating agent in a concentration effective for prolonging the presence of the at least one non-hexose sugar alcohol and/or at least one non-hexose sugar alcohol precursor in a patient's throat to treat the sore throat condition. | 01-07-2016 |
20160113992 | COMBINATIONS OF EXTRACTS OF SERENOA REPENS AND LIPOPHILIC EXTRACTS OF ZINGIBER OFFICINALIS AND ECHINACEA ANGUSTIFOLIA, THE USE THEREOF, AND FORMULATIONS CONTAINING THEM - Disclosed are compositions containing an extract of | 04-28-2016 |
20160151441 | FORMULATIONS CONTAINING EXTRACTS OF ECHINACEA ANGUSTIFOLIA AND ZINGIBER OFFICINALE WHICH ARE USEFUL IN REDUCING INFLAMMATION AND PERIPHERAL PAIN | 06-02-2016 |